Doppler-derived coronary flow velocity reserve (CFVR) of left anterior descending (LAD) artery is an effective tool to predict overall mortality. The aim was to investigate the capability of CFVR to predict outcome in an unselected cohort of patients older than 80 years having stress echo negative by wall motion criteria.
Introduction
Population ageing is a generalized process across western countries, and it is expected to continue in future decades. 1 In particular, the proportion of individuals aged 80 and over in EU Member States currently represents 4.7% of the total population, and is projected to increase to 12.1% in 2060. 2 As the prevalence and severity of coronary artery disease (CAD) show a striking growth with age, 3, 4 the assessment of risk in octogenarians is and will be increasingly important in the next future. Unfortunately, in these patients, the predictive value of a test may be negatively affected by reduced life expectancy. On the other hand, due to the high prevalence of CAD in this subset, a negative test results may likely be a false-negative one. 5 Therefore, a non-invasive strategy for risk stratification may have important clinical implications. Exercise electrocardiography shows limited feasibility in very old patients, mainly due to neuromuscular weakness, physical deconditioning or neurological, orthopaedic, peripheral vascular, or respiratory limitations. In addition, test specificity declines as age increases 5 because of repolarization abnormalities on resting electrocardiogram due to hypertension, 6 left ventricular hypertrophy, 6, 7 or digoxin intake. 8 Stress echocardiography has been found to confer effective prognostic contribution in elderly individuals. 9 -16 In our previous experience, the presence and extent of ischaemia at stress echo was a strong indicator of future non-fatal myocardial infarction in patients older than 80 years, independently by the evidence of wall motion abnormalities on resting echo. However, it failed to predict mortality. 16 Doppler-derived coronary flow velocity reserve (CFVR) of left anterior descending (LAD) artery during vasodilatory stress proved to be a highly feasible 17 and effective modality to predict major adverse cardiac events (MACEs) in unselected populations, 18 as well as in diabetic 17 and hypertensive individuals. 19 Lately, it was an independent indicator of mortality in a large series of patients with known or suspected CAD, providing incremental prognostic information over wall motion analysis. 20 Whether these results apply to very old patients, however, remains unsettled. Accordingly, in this prospective, multicentre, observational study, we sought to investigate the capability of CFVR of LAD to predict mortality and MACE in an unselected cohort of patients older than 80 years having stress echo negative by wall motion criteria.
Methods Patients
The initial population relied on 385 patients aged ≥80 years who were evaluated at four Italian Cardiology Institutions (Lucca, Mestre, Cesena, and Pisa) from August 2003 to December 2012 for enrolment in a study focused to assess the prognostic value of CFVR in the setting of known or suspected CAD. The study design is observational, not randomized, prospective and patients were entered the databank at the time of initial assessment. All subjects underwent stress echocardiography with wall motion and CFVR assessment of LAD by transthoracic Doppler ultrasound. No subject had significant valvular heart disease, comorbidity reducing life expectancy to ,1 year (cancer, end-stage renal or liver disease, or severe obstructive pulmonary disease), or inadequate acoustic window for imaging of left ventricle (for 2D echo) and LAD flow Doppler (for CFVR assessment). All patients had a negative stress echocardiography result by wall motion criteria. 21 hypertension, 22 and hypercholesterolaemia 23 were defined according to standard definitions. All patients were followed up for a median of 21 months (first quartile 9 and third quartile 38), with a minimum pre-defined follow-up time of 3 months.
Stress echocardiography
Transthoracic stress echocardiographic studies were performed with commercially available ultrasound machine (Sonos 7500 or iE 33, Philips Ultrasound, Andover, MA, USA; Vivid System 7, GE/Vingmed, Milwaukee, WI, USA; Sequoia C256 Acuson Siemens Mountain View, CA, USA) equipped with a multifrequency phased-array sector scan probe (S3-S8 or V3-V7) and with second-harmonic technology. Twodimensional echocardiography and 12-lead electrocardiographic monitoring were performed in combination with high-dose dipyridamole (up to 0.84 mg over 6 min). 24 Echocardiographic images were semiquantitatively assessed using a 17-segment, 4-point scale model of the left ventricle. 25 A wall motion score index was derived by dividing the sum of individual segment scores by the number of interpretable segments. Ischaemia was defined as stress-induced new wall motion abnormality. CFVR was assessed during the standard stress echo examination by an intermittent imaging of both wall motion and LAD flow. 24 Coronary flow in the mid-distal portion of LAD was searched in the low parasternal long-axis section under the guidance of colour Doppler flow mapping. 24 All studies were digitally stored to simplify off-line reviewing and measurements. Coronary flow parameters were analysed off-line by use of the built-in calculation package of the ultrasound unit. Flow velocities were measured at least twice for each study: at baseline and at peak stress (before aminophylline injection). At each time point, three optimal profiles of peak diastolic Doppler flow velocities were measured, and the results were averaged. CFVR was defined as the ratio between hyperaemic peak and basal peak diastolic coronary flow velocities. All observers were trained by the same senior investigator (F.R.), who granted consistency in data acquisition, storage, and interpretation, also through intensive joint reading sessions. All investigators of contributing centres passed quality control criteria for regional wall motion and Doppler interpretation prior to entering the study as previously described. 26 The previously assessed intra-and interobserver variability for measurements of Doppler recordings and regional wall motion analysis assessment were ,10%. 27 In our previous experience, the assessment of CFVR of LAD had 94% feasibility. 17 
Follow-up
Outcome was determined from patients' interview at the outpatient clinic, hospital chart reviews, and telephone interviews with the patient, his/her close relative or referring physician. Death and non-fatal myocardial infarction were registered as clinical events. Coronary revascularization (surgery or percutaneous interventions) was also recorded.
To avoid misclassification of the cause of death, 28 overall mortality was considered. Myocardial infarction was defined by typical symptoms, electrocardiographic, and cardiac enzyme changes. Follow-up data were analysed for the prediction of death and MACE (death and non-fatal myocardial infarction).
Statistical analysis
Continuous variables are expressed as mean + SD. Differences between groups were compared using Student's t-and x 2 test, as appropriate.
Event rates were estimated with Kaplan-Meier curves and compared by the log-rank test. Patients undergoing coronary revascularization were censored at the time of the procedure. Only the first event was taken into account. Annual event rates were obtained from Kaplan-Meier estimates to take censoring of the data into account. A receiver operating characteristic analysis was used to obtain the best prognostic predictor for CFVR variation. The association of selected variables with outcome was assessed with the Cox's proportional hazard model using univariate and stepwise multivariate procedures. A significance of 0.05 was required for a variable to be included into the multivariate model, while 0.1 was the cut-off value for exclusion. Hazard ratios (HRs) with the corresponding 95% confidence interval (CI) were estimated. Statistical significance was set at P , 0.05. Moreover, clinical findings, resting wall motion abnormality (RWMA), and CFVR were sequentially included into the model. Global X 2 value of the model was calculated from the log-likelihood ratio; a significant increase after the addition of further variables indicated an incremental prognostic value. Statistical Package for the Social Sciences (SPSS release 13.0, Chicago, IL, USA) was used for analysis.
Results

Stress echocardiography
In Figure 1 ). In Figure 2 is illustrated the annual mortality by main clinical and echocardiographic findings. Annual mortality in the whole study population was 5.8%; it was 9.8% in patients with CFVR ≤1.93 and 3. Coronary flow reserve in octogenarians those with CFVR .1.93 (P ¼ 0.001). The presence of RWMA was related to an annual mortality of 11.6% (Figure 2) . At incremental analysis, global X 2 of clinical model for the prediction of mortality was 14.9 (P ¼ 0.06); sequential inclusion of RWMA and CFR ≤1.93 increased it by 86% (27.9; P ¼ 0.001) and 22% (34.5; P , 0.0001), respectively ( Figure 3) . When MACEs were the clinical end point, CFVR ≤1.93 and RWMA were also the multivariable prognostic indicators ( Table 3) . The 4-year event rate was significantly higher in patients with CFVR ≤1.93 than in those with CFVR .1.93 (42 vs. 18%, P , 0.0001; Figure 1 ). In Figure 4 is depicted the annual MACE rate by main clinical and echocardiographic features. The annual MACE rate in the entire study group was 8.0%; it was 14.8% in the subset of patients with CFVR ≤1.93 and 4.5% in those with CFVR .1.93 (P , 0.0001; Figure 4 ). The annual MACE rate was greater in patients with CFVR ≤1.93 than in those with CFVR .1.93, both considering the sample with RWMA (21.2 vs. 11.3%; P ¼ 0.05) and the sample without RWMA (11.2 vs. 2.1%; P , 0.0001). At incremental analysis, global X 2 of clinical model for the prediction of MACE was 18.0 (P ¼ 0.02); it increased by 86% (33.4; P , 0.0001) and 42% (47.4; P , 0.0001), respectively, after the inclusion of RWMA and CFR ≤1.93 into the model ( Figure 3) .
Discussion
Ageing is a major risk factor for cardiovascular disease 29 ; in fact, by acting with other variables, such as gene expression, environment, and disease, it provokes structural and functional changes in the cardiovascular system including coronary circulation. 29, 30 In particular, the atherosclerotic risk shows a linear association with age and the prevalence of CAD is 35% in men and 20% in women aged ≥80 years. 3 However, the effect of age is also exerted on the coronary microvasculature because of reduction in endothelial function. 30 The high prevalence of arterial hypertension, 3 diabetes mellitus, 31 and left ventricular hypertrophy 32 in old individuals contributes to coronary microvascular disease. Indeed, coronary flow reserve measured with PET 33 or transthoracic Doppler 34 in subjects with no CAD progressively reduces advancing with age. Accordingly, the criteria of normality for coronary flow reserve should be normalized for age. In the current study, on an unselected patient sample older than 80 years, a CFVR of ≤1.93 was the best value to identify patients with unfavourable outcome capable to independently predict overall mortality and MACE in the face of a negative stress echo result by wall motion criteria. Although the presence of RWMA also conferred a markedly increased risk, a CFVR of ≤1.93 provided an incremental prognostic value over clinical evaluation and RWMA both considering mortality and MACE as the clinical end points. The management of this set of patients remains a clinical dilemma because most of the studies on risk stratification had upper age limits or did not present age-specific results. Moreover, the population is ageing and the search for an effective risk stratification in this subset is needed to avoid useless and potentially harmful exams and procedures which would not improve outcome.
Comparison with previous studies
A previous report from our group 16 demonstrated that, in an unselected patient population older than 80 years, stress echocardiography was able to predict myocardial infarction but not mortality. The higher the extent of ischaemia, as expressed by the variation of wall motion score index between rest and peak stress, the higher the incidence rate of myocardial infarction. Therefore, the presence Coronary flow reserve in octogenarians of inducible myocardial ischaemia at stress echocardiography was not per se a marker of mortality. Then, any intervention is unable to prolong survival. A few previous studies were consistent with our findings in octogenarians. In a report on 335 patients aged ≥80 years, wall motion score index at peak of dobutamine stress, an established index of the extent of myocardium 'at risk' incorporating ischaemic as well as necrotic segments independently predicted cardiac death and myocardial infarction. 13 Furthermore, stress function index, defined as the ratio between wall motion score index during dobutamine stress to resting left ventricular ejection fraction, was a strong indicator of overall mortality and major cardiac events in 227 octogenarians. 14 However, both clinical end points had comparable incidence in patients with and without inducible ischaemia.
14 Finally, wall motion score index at peak of dobutamine stress was a multivariable predictor of all-cause mortality and the composite end point of myocardial infarction or late revascularization, while increased or unchanged left ventricular end-systolic volume was an additional indicator of mortality in 2288 patients aged ≥75 years. 15 However, our study specifically investigated the ability of CFVR, as assessed by transthoracic Doppler of LAD, to predict mortality in the absence of inducible ischaemia. There are no other reports showing that a reduced CFVR increased mortality in a very old segment of patients. The association between depressed CFVR and future cardiac events has been extensively documented in an unselected patient populations, 18 as well as in hypertensive patients 19 and diabetics, 17 and in patients with normal or near-normal coronary arteries. 35, 36 The present results expand to octogenarians the prognostic consequences deriving from CFVR assessment. Interestingly, a CFVR of .1.93 was predictive of benign prognosis. This is a novel and clinically relevant finding of our study, emphasizing the elusive link between stress echo result and survival in a high-risk population with reduced life expectancy such as that of patients aged ≥80 years.
Clinical implications
Ageing is a gradual and generalized process. In fact, apart from southern Africa, life expectancy at birth has increased for the whole population in the world by .20 years in the last half a century, 37 currently resulting 80 years or more in 16% of countries, the majority of which are developed countries. 38 Cardiovascular disease is the leading cause of mortality in persons aged ≥80 years and CAD account for half of deaths. 3 Accordingly, the ageing population is destined to increase the costs associated with the treatment of cardiovascular diseases, which are increasing rapidly with an expected almost linear growth over the next two decades up to triple compared with current costs. 39 The search for effective tools for prognostic stratification of patients of advanced age should be considered, therefore, an important goal to optimize therapeutic strategies containing medical expenditure. The results of the current study have a potential impact in the management of octogenarians with known or suspected CAD. In particular, no further investigation is justified for those with CFVR of LAD .1.93 and stress echo negative for ischaemia due to their low risk. Moreover, the lack of RWMA and preserved CFVR identifies a subset of patients at very low risk with an annual hard event rate of only 2.1%. On the contrary, angiographic evaluation should be considered for patients with CFVR of LAD ≤1.93 especially in the case of concomitant RWMA. Of some interest, medical therapy at time of testing had no impact on outcome, confirming that CFVR is not modulated by anti-ischaemic treatment. 19, 39 However, a clinical strategy to evaluate very old age patients remains unsettled: Doppler-derived CFVR is a suitable and safe tool for risk stratification and may have an additive role in the presence of a negative test result dissecting the different components of CAD (macro-and microvascular).
Study limitations
In this study, there was no central reading. Stress echocardiography and CFVR measurement were interpreted in the peripheral centres and entered directly in the data bank. This system allowed substantial sparing of human and technological resources, but it was also the logical pre-requisite for a large scale study, designed to represent the realistic performance of the test rather than the results of a single laboratory-or even a single person-working in a highly dedicated echo laboratory. Because the assessment of the echocardiograms was qualitative and subjective, variability in reading the echocardiograms might have modulated the results of individual centres. However, all our readers in individual centres had a long-lasting experience in echocardiography, passed the quality control in stress echo reading as previously described, 26 and had extensive experience on performance and interpretation of CFVR also through joint reading sessions. The CFVR was sampled only on LAD. There is no doubt that the three coronaries approach would be more fruitful, but at present it remains too technically challenging for a large scale assessment. The available technology and echocardiographist expertise would allow the detection of CFVR of the three vascular territories, but this pathophysiological approach would make the test highly unfeasible on a routine basis. Our main aim was to test the effectiveness, not only the efficacy, of the combined information on wall motion and CFVR in a single test. A scale of frailty was not used to assess the overall status of the sample under investigation: the simple indication to stress echocardiography was considered a pre-requisite of well managing activities. The indication to coronary revascularization was based on several factors being stress echo result only but one of many. Echocardiographers performing stress echo were not involved in clinical management of patients and this may explain, at least in part, the decision to revascularize patients in the face of a negative test result.
Conclusions
In octogenarians, a reduced CFVR of LAD in the face of a stress echo negative for wall motion abnormalities may be a suitable tool to risk stratify the subset at higher risk of mortality and MACE.
